Tango Therapeutics Inc (TNGX)
7.55
-0.24
(-3.08%)
USD |
NASDAQ |
May 17, 16:00
7.55
0.00 (0.00%)
After-Hours: 20:00
Tango Therapeutics Cash from Investing (Quarterly): -11.20M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -11.20M |
| December 31, 2023 | 33.85M |
| September 30, 2023 | -56.66M |
| June 30, 2023 | 32.69M |
| March 31, 2023 | 31.55M |
| December 31, 2022 | -12.60M |
| September 30, 2022 | 15.23M |
| Date | Value |
|---|---|
| June 30, 2022 | 35.49M |
| March 31, 2022 | -11.72M |
| December 31, 2021 | -45.21M |
| September 30, 2021 | -152.21M |
| June 30, 2021 | -6.625M |
| March 31, 2021 | 20.61M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-152.21M
Minimum
Sep 2021
35.49M
Maximum
Jun 2022
-9.755M
Average
-6.625M
Median
Jun 2021
Cash from Investing (Quarterly) Benchmarks
| Aquestive Therapeutics Inc | -0.029M |
| 2seventy bio Inc | 21.83M |
| NovaBay Pharmaceuticals Inc | 1.068M |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -37.86M |
| Cash from Financing (Quarterly) | 42.98M |
| Free Cash Flow | -122.03M |
| Free Cash Flow Per Share (Quarterly) | -0.3518 |
| Free Cash Flow to Equity (Quarterly) | -38.05M |
| Free Cash Flow to Firm (Quarterly) | -38.05M |
| Free Cash Flow Yield | -16.31% |